The opposite associations of lycopene and body fat mass with humoral immunity in type 2 diabetes mellitus: A possible role in atherogenesis

Iranian Journal of Allergy, Asthma and Immunology

Volumn 6, Issue 2, 2007, Pages 79-87

  Neyestani, Tirang R ^a   Shariat Zadeh, Nastaran ^a   Gharavi, A'Azam ^a   Kalayi, Ali ^a   Khalaji, Niloufar ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes mellitus Type 2; Fat mass; Immunity; Lycopene; Oxidative stress

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LOW DENSITY LIPOPROTEIN; LYCOPENE; MALONALDEHYDE;

ADAPTIVE IMMUNITY; ADULT; AGED; ARTICLE; ATHEROGENESIS; BODY FAT; BODY MASS; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FEMALE; HEART PROTECTION; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; IRAN; LIPID PEROXIDATION; MALE; MEDICAL SOCIETY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; T LYMPHOCYTE; TREATMENT DURATION;

ADIPOSE TISSUE; ANTIBODY FORMATION; ANTIOXIDANTS; ATHEROSCLEROSIS; BETA CAROTENE; CAROTENOIDS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; IMMUNOGLOBULINS; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 34547620565     PISSN: 17351502     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Turner RC. The U.K. Prospective Diabetes Study. A review. Diabetes Care 1998; 21 Suppl 3:C35-8.
2. Nicolucci A, Carinci F, Ciampi A. Stratifying patients at risk of diabetic complications: an integrated look at clinical, socioeconomic, and care-related factors. SIDAMD Italian Study Group for the Implementation of the St. Vincent Declaration. Diabetes Care 1998; 21(9):1439-44.
3. Bo S, Ciccone G, Gancia R, Rosato R, Grassi G, Merletti F, et al. Mortality within the first 10 years of the disease in type 2 diabetic patients. Nutr Metab Cardiovasc Dis 2006; 16(1):8-12.
4. Hatunic M, Burns N, Finucane F, Mannion C, Nolan JJ. Contrasting clinical and cardiovascular risk status between early and later onset type 2 diabetes. Diab Vasc Dis Res 2005; 2(2):73-5.
5. Chen X, Niroomand F, Liu Z, Zankl A, Katus HA, Jahn L, et al. Expression of nitric oxide related enzymes in coronary heart disease. Basic Res Cardiol 2006; 101(4):346-53.
6. Madamanchi NR, Tchivilev I, Runge M. Genetic markers of oxidative stress and coronary atherosclerosis. Curr Atheroscler Rep 2006; 8(3):177-83.
7. Ueda S, Yasunari K. What we learnt from randomized clinical trials and cohort studies of antioxidant vitamin? Focus on vitamin E and cardiovascular disease Curr Pharm Biotechnol 2006; 7(2):69-72.
8. Minuz P, Fava C, Cominacini L. Oxidative stress, antioxidants, and vascular damage. Br J Clin Pharmacol 2006; 61(6):774-7.
9. Xia Z, Guo Z, Nagareddy PR, Yuen V, Yeung E, McNeill JH. Antioxidant N-acetylcysteine restores myocardial Mn-SOD activity and attenuates myocardial dysfunction in diabetic rats. Eur J Pharmacol 2006; 544(1-3):118-25.
10. Song MK, Rosenthal MJ, Song AM, Yang H, Ao Y, Yamaguchi DT. Raw vegetable food containing high cyclo (his-pro) improved insulin sensitivity and body weight control.Metabolism 2005; 54(11):1480-9.
11. Gur S, Karahan ST, Ozturk B, Badilli M. Effect of ascorbic acid treatment on endothelium-dependent and neurogenic relaxation of corpus cavernosum from middle-aged non-insulin dependent diabetic rats. Int J Urol 2005; 12(9):821-8.
12. Anderson RA, Evans LM, Ellis GR, Khan N, Morris K, Jackson SK, et al. Prolonged deterioration of endothelial dysfunction in response to postprandial lipaemia is attenuated by vitamin C in Type 2 diabetes. Diabet Med 2006; 23(3):258-64.
13. Clarke MW, Ward NC, Wu JH, Hodgson JM, Puddey IB, Croft KD. Supplementation with mixed tocopherols increases serum and blood cell gamma-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes. Am J Clin Nutr 2006; 83(1):95-102.
14. Neri S, Signorelli SS, Torrisi B, Pulvirenti D, Mauceri B, Abate G, et al. Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls. Clin Ther 2005; 27(11):1764-73.
15. Baliarsingh S, Beg ZH, Ahmad J. The therapeutic impacts of tocotrienols in type 2 diabetic patients with hyperlipidemia. Atherosclerosis 2005; 182(2):367-74.
16. Chen H, Karne RJ, Hall G, Campia U, Panza JA, Cannon RO 3rd, et al. High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance. Am J Physiol Heart Circ Physiol 2006; 290(1):H137-45.
17. Stephens JW, Gable DR, Hurel SJ, Miller GJ, Cooper JA, Humphries SE. Increased plasma markers of oxidative stress are associated with coronary heart disease in males with diabetes mellitus and with 10-year risk in a prospective sample of males. Clin Chem 2006; 52(3):446-52.
18. Lankin VZ, Lisina MO, Arzamastseva NE, Konovalova GG, Nedosugova LV, Kaminnyi AI, et al. Oxidative stress in atherosclerosis and diabetes. Bull Exp Biol Med 2005; 140(1):41-3.
19. Weisburger JH. Lycopene and tomato products in health promotion. Exp Biol Med (Maywood) 2002; 227(10):924-7.
20. Kim GY, Kim JH, Ahn SC, Lee HJ, Moon DO, Lee CM, et al. Lycopene suppresses the lipopolysaccharide-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and nuclear factor-kappaB. Immunology 2004; 113(2):203-11
21. Briviba K, Kulling SE, Moseneder J, Watzl B, Rechkemmer G, Bub A, et al. Effects of supplementing a low-carotenoid diet with a tomato extract for 2 weeks on endogenous levels of DNA single strand breaks and immune functions in healthy non-smokers and smokers. Carcinogenesis 2004; 25(12):2373-8.
22. Watzl B, Bub A, Briviba K, Rechkemmer G. Supplementation of a low-carotenoid diet with tomato or carrot juice modulates immune functions in healthy men. Ann Nutr Metab 2003; 47(6):255-61.
23. Watzl B, Bub A, Brandstetter BR, Rechkemmer G. Modulation of human T-lymphocyte functions by the consumption of carotenoid-rich vegetables. Br J Nutr 1999; 82(5):383-9.
24. Rice-Evans, Miller NJ. Total antioxidant status in plasma and body fluids. Methods Enzymol 1994; 234:279-93.
25. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978; 90(1):37-43.
26. Meydani SN, Wu D, Santos MS, Hayek MG. Antioxidants and immune response in aged persons: overview of present evidence. Am J Clin Nutr 1995; 62(6 Suppl):1462S-1476S.
27. Gurfinkel E, Lernoud V. The role of infection and immunity in atherosclerosis. Expert Rev Cardiovasc Ther 2006; 4(1):131-7.
28. Kobayashi K, Lopez LR, Shoenfeld Y, Matsuura E. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis. Ann N Y Acad Sci 2005; 1051:442-54.
29. Nilsson J. Regulating protective immunity in atherosclerosis. Circ Res 2005; 96(4):395-7.
30. Caligiuri G, Nicoletti A, Poirier B, Hansson GK. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest 2002; 109(6):745-53.
31. Saha A, Adak S, Chowdhury S, Bhattacharyya M. Enhanced oxygen releasing capacity and oxidative stress in diabetes mellitus and diabetes mellitus-associated cardiovascular disease: a comparative study. Clin Chim Acta 2005; 361(1-2):141-9.
32. Shaw PX. Rethinking oxidized low-density lipoprotein, its role in atherogenesis and the immune responses associated with it. Arch Immunol Ther Exp (Warsz) 2004; 52(4):225-39.
33. Weber C, Erl W, Weber PC. Enhancement of monocyte adhesion to endothelial cells by oxidatively modified low-density lipoprotein is mediated by activation of CD11b. Biochem Biophys Res Commun 1995; 206(2):621-8.
34. Horkko S, Miller E, Dudl E, Reaven P, Curtiss LK, Zvaifler NJ, et al. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest 1996; 98(3):815-25.
35. Arab L, Steck S. Lycopene and cardiovascular disease. Am J Clin Nutr 2000; 71(Suppl):1691S-5S.
36. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114(12):1752-61.
37. Sibley SD, Thomas W, de Boer I, Brunzell JD, Steffes MW. Gender and elevated albumin excretion in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort: role of central obesity. Am J Kidney Dis 2006; 47(2):223-32.
38. McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S. Resistin, central obesity, and type 2 diabetes. Lancet 2002; 359(9300):46-7.
39. EI Midaoui AE, de Champlain J. Effects of glucose and insulin on the development of oxidative stress and hypertension in animal models of type 1 and type 2 diabetes. J Hypertens 2005; 23(3):581-8.
40. Ganji V, Kafai MR; Third National Health and Nutrition Examination Survey, 1998-1994. Population determinants of serum lycopene concentrations in the United States: data from the Third National Health and Nutrition Examination Survey, 1988-1994. J Nutr 2005; 135(3):567-72.
41. Neyestani TR, Alipour-Birgani R, Siassi F, Rajayi M, Djalali M, Mohamadi M. Glycemic optimization may reduce lipid peroxidation independent of weight and blood lipid changes in Type 2 diabetes mellitus. Diabetes Nutr Metab 2004; 17(5):275-9.